Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 10/2016

02.04.2016 | Review Article

Contribution of 18F-FDG PET in the diagnostic assessment of fever of unknown origin (FUO): a stratification-based meta-analysis

verfasst von: Florent L. Besson, Philippe Chaumet-Riffaud, Margot Playe, Nicolas Noel, Olivier Lambotte, Cécile Goujard, Alain Prigent, Emmanuel Durand

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to quantify the contribution of FDG PET to the diagnostic assessment of fever of unknown origin (FUO), taking into account the diagnostic limitations resulting from the composite nature of this entity.

Methods

The PubMed/MEDLINE database was searched from 2000 to September 2015. Original articles fulfilling the following criteria were included: (1) FUO as the initial diagnosis, (2) no immunosuppressed or nosocomial condition, (3) final diagnosis not based on PET, (4) a follow-up period specified, (5) adult population, and (6) availability of adapted data for calculation of odds ratios (ORs). ORs were computed for each study and then pooled using a random effects model. Stratification-based sensitivity analyses were finally performed using the following prespecified criteria: (a) study design, (b) PET device, (c) geographic area, and (d) follow-up period.

Results

A meta-analysis of the 14 included studies showed that normal PET findings led to an increase in the absolute final diagnostic rate of 36 % abnormal PET findings to an increase of 83 %, corresponding to a pooled OR of 8.94 (95 % CI 4.18 – 19.12, Z = 5.65; p < 0.00001). The design of the studies influenced the results (OR 2.92, 95 % CI 1.00 – 8.53 for prospective studies; OR 18,57, 95 % CI 7.57 – 45.59 for retrospective studies; p = 0.01), whereas devices (dedicated or hybrid), geographic area and follow-up period did not.

Conclusion

Abnormal PET findings are associated with a substantially increased final diagnostic rate in FUO. Consequently, FDG PET could be considered for inclusion in the first-line diagnostic work-up of FUO. Further randomized prospective studies with standardized FDG PET procedures are warranted to confirm this first-line position.
Literatur
3.
Zurück zum Zitat Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med. 2001;42:1551–5.PubMed Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med. 2001;42:1551–5.PubMed
4.
Zurück zum Zitat Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301–6.PubMed Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301–6.PubMed
5.
Zurück zum Zitat Gamelli RL, Liu H, He LK, Hofmann CA. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J Leukoc Biol. 1996;59:639–47.PubMed Gamelli RL, Liu H, He LK, Hofmann CA. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J Leukoc Biol. 1996;59:639–47.PubMed
6.
Zurück zum Zitat Fukuzumi M, Shinomiya H, Shimizu Y, Ohishi K, Utsumi S. Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1. Infect Immun. 1996;64:108–12.PubMedPubMedCentral Fukuzumi M, Shinomiya H, Shimizu Y, Ohishi K, Utsumi S. Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1. Infect Immun. 1996;64:108–12.PubMedPubMedCentral
7.
9.
Zurück zum Zitat Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med. 1992;152:21–2.CrossRefPubMed Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med. 1992;152:21–2.CrossRefPubMed
10.
Zurück zum Zitat Durack DT, Street AC. Fever of unknown origin – reexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35–51.PubMed Durack DT, Street AC. Fever of unknown origin – reexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35–51.PubMed
11.
Zurück zum Zitat Nazar AH, Naswa N, Sharma P, Soundararajan R, Bal C, Malhotra A, et al. Spectrum of 18F-FDG PET/CT findings in patients presenting with fever of unknown origin. AJR Am J Roentgenol. 2012;199:175–85. doi:10.2214/AJR.11.7570.CrossRefPubMed Nazar AH, Naswa N, Sharma P, Soundararajan R, Bal C, Malhotra A, et al. Spectrum of 18F-FDG PET/CT findings in patients presenting with fever of unknown origin. AJR Am J Roentgenol. 2012;199:175–85. doi:10.​2214/​AJR.​11.​7570.CrossRefPubMed
13.
Zurück zum Zitat Sioka C, Assimakopoulos A, Fotopoulos A. The diagnostic role of (18)F fluorodeoxyglucose positron emission tomography in patients with fever of unknown origin. Eur J Clin Invest. 2015;45:601–8. doi:10.1111/eci.12439.CrossRefPubMed Sioka C, Assimakopoulos A, Fotopoulos A. The diagnostic role of (18)F fluorodeoxyglucose positron emission tomography in patients with fever of unknown origin. Eur J Clin Invest. 2015;45:601–8. doi:10.​1111/​eci.​12439.CrossRefPubMed
17.
Zurück zum Zitat Buysschaert I, Vanderschueren S, Blockmans D, Mortelmans L, Knockaert D. Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med. 2004;15:151–6. doi:10.1016/j.ejim.2004.01.018.CrossRefPubMed Buysschaert I, Vanderschueren S, Blockmans D, Mortelmans L, Knockaert D. Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med. 2004;15:151–6. doi:10.​1016/​j.​ejim.​2004.​01.​018.CrossRefPubMed
18.
Zurück zum Zitat Bleeker-Rovers CP, Vos FJ, Mudde AH, Dofferhoff AS, de Geus-Oei LF, Rijnders AJ, et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging. 2007;34:694–703. doi:10.1007/s00259-006-0295-z.CrossRefPubMed Bleeker-Rovers CP, Vos FJ, Mudde AH, Dofferhoff AS, de Geus-Oei LF, Rijnders AJ, et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging. 2007;34:694–703. doi:10.​1007/​s00259-006-0295-z.CrossRefPubMed
22.
23.
Zurück zum Zitat Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun. 2001;22:779–83.CrossRefPubMed Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun. 2001;22:779–83.CrossRefPubMed
24.
Zurück zum Zitat Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging. 2004;31:29–37. doi:10.1007/s00259-003-1338-3.CrossRefPubMed Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging. 2004;31:29–37. doi:10.​1007/​s00259-003-1338-3.CrossRefPubMed
27.
29.
Zurück zum Zitat Sheng JF, Sheng ZK, Shen XM, Bi S, Li JJ, Sheng GP, et al. Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown origin. Eur J Intern Med. 2011;22:112–6. doi:10.1016/j.ejim.2010.09.015.CrossRefPubMed Sheng JF, Sheng ZK, Shen XM, Bi S, Li JJ, Sheng GP, et al. Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown origin. Eur J Intern Med. 2011;22:112–6. doi:10.​1016/​j.​ejim.​2010.​09.​015.CrossRefPubMed
31.
Zurück zum Zitat de Kleijn EM, Vandenbroucke JP, van der Meer JW. Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore). 1997;76:392–400.CrossRef de Kleijn EM, Vandenbroucke JP, van der Meer JW. Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore). 1997;76:392–400.CrossRef
32.
Zurück zum Zitat Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med. 2003;163:545–51.CrossRefPubMed Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med. 2003;163:545–51.CrossRefPubMed
33.
Zurück zum Zitat de Kleijn EM, van der Meer JW. Fever of unknown origin (FUO): report on 53 patients in a Dutch university hospital. Neth J Med. 1995;47:54–60.CrossRefPubMed de Kleijn EM, van der Meer JW. Fever of unknown origin (FUO): report on 53 patients in a Dutch university hospital. Neth J Med. 1995;47:54–60.CrossRefPubMed
35.
Zurück zum Zitat Balink H, Tan SS, Veeger NJ, Holleman F, van Eck-Smit BL, Bennink RJ, et al. (18)F-FDG PET/CT in inflammation of unknown origin: a cost-effectiveness pilot-study. Eur J Nucl Med Mol Imaging. 2015;42:1408–13. doi:10.1007/s00259-015-3010-0.CrossRefPubMed Balink H, Tan SS, Veeger NJ, Holleman F, van Eck-Smit BL, Bennink RJ, et al. (18)F-FDG PET/CT in inflammation of unknown origin: a cost-effectiveness pilot-study. Eur J Nucl Med Mol Imaging. 2015;42:1408–13. doi:10.​1007/​s00259-015-3010-0.CrossRefPubMed
36.
Zurück zum Zitat Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med. 2003;253:263–75.CrossRefPubMed Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med. 2003;253:263–75.CrossRefPubMed
37.
Zurück zum Zitat Kjaer A, Lebech AM, Eigtved A, Hojgaard L. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004;31:622–6. doi:10.1007/s00259-003-1425-5.CrossRefPubMed Kjaer A, Lebech AM, Eigtved A, Hojgaard L. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004;31:622–6. doi:10.​1007/​s00259-003-1425-5.CrossRefPubMed
Metadaten
Titel
Contribution of 18F-FDG PET in the diagnostic assessment of fever of unknown origin (FUO): a stratification-based meta-analysis
verfasst von
Florent L. Besson
Philippe Chaumet-Riffaud
Margot Playe
Nicolas Noel
Olivier Lambotte
Cécile Goujard
Alain Prigent
Emmanuel Durand
Publikationsdatum
02.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 10/2016
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-016-3377-6

Weitere Artikel der Ausgabe 10/2016

European Journal of Nuclear Medicine and Molecular Imaging 10/2016 Zur Ausgabe